Biaffin

Newsletter

kinases protein kinase inhibitors signaling activators kinase substrates antibodies bioluminescence assays
Recombinant Human ROR1 Protein (Kringle domain), His Tag (MALS verified), 50 µg  

Recombinant Human ROR1 Protein (Kringle domain), His Tag (MALS verified), 50 µg

Recombinant Human / Cynomolgus / Rhesus macaque ROR1 Protein, Kringle domain (Asn 308 - Asp 395, Kringle domain), produced in human 293 cells (HEK293), His Tag (MALS verified)

Synonym: Recombinant human Protein, ROR1,NTRKR1

More details

RO1-H5223-50

Availability: within 7 days

533,00 €

Background
Tyrosine-protein kinase transmembrane receptor ROR1 is also known as Neurotrophic tyrosine kinase, receptor-related 1 (NTRKR1), which belongs to the protein kinase superfamily or tyr protein kinase family or ROR subfamily. ROR1 contains 1 FZ (frizzled) domain, 1 Ig-like C2-type (immunoglobulin-like) domain, 1 kringle domain, 1 protein kinase domain. ROR1 is expressed at high levels during early embryonic development. The expression levels drop strongly around day 16 and there are only very low levels in adult tissues. Isoform Short is strongly expressed in fetal and adult CNS and in a variety of human cancers, including those originating from CNS or PNS neuroectoderm. ROR1 could interact with casein kinase 1 epsilon (CK1ε) to activate phosphoinositide 3-kinase-mediated AKT phosphorylation and cAMP-response-element-binding protein (CREB), which was associated with enhanced tumor-cell growth.

Source
Recombinant Human / Cynomolgus / Rhesus macaque ROR1 (308-395, Kringle domain), His Tag (RO1-H5223) is expressed from human 293 cells (HEK293). It contains AA Asn 308 - Asp 395 (Accession # Q01973-1). In the region Gln 30 - Glu 403, the AA sequence of Human, Cynomolgus and Rhesus macaque ROR1 are homologus.
Predicted N-terminus: Asn 308

Molecular Characterization
This protein carries a polyhistidine tag at the C-terminus.
The protein has a calculated MW of 11.2 kDa. The protein migrates as 16-18 kDa under reducing (R) condition (SDS-PAGE) due to glycosylation.

Endotoxin
Less than 1.0 EU per μg by the LAL method.

Purity
>95% as determined by SDS-PAGE.
>90% as determined by SEC-MALS.

Formulation
Lyophilized from 0.22 μm filtered solution in PBS, pH7.4. Normally trehalose is added as protectant before lyophilization.

Reconstitution
See Certificate of Analysis for reconstitution instructions and specific concentrations.

Storage
For long term storage, the product should be stored at lyophilized state at -20°C or lower.
Please avoid repeated freeze-thaw cycles.
This product is stable after storage at:
-20°C to -70°C for 12 months in lyophilized state;
-70°C for 3 months under sterile conditions after reconstitution.

Clinical and Translational Updates

(1) "A Small Molecule Targeting the Intracellular Tyrosine Kinase Domain of ROR1 (KAN0441571C) Induced Significant Apoptosis of Non-Small Cell Lung Cancer (NSCLC) Cells"
Ghaderi, Okhovat, Lehto et al
Pharmaceutics (2023) 15 (4)
(2) "YAP/BRD4-controlled ROR1 promotes tumor-initiating cells and hyperproliferation in pancreatic cancer"
Yamazaki, Hino, Usuki et al
EMBO J (2023)
(3) "Targeting ROR1 inhibits glucocorticoid-induced gastric cancer growth"
Wang, Guo, Ma et al
Steroids (2023) 195, 109239
Showing 1-3 of 513 papers.

The following products could also be interesting for you: